000289449 001__ 289449
000289449 005__ 20250318095250.0
000289449 0247_ $$2doi$$a10.1093/mutage/geae012
000289449 0247_ $$2pmid$$apmid:38606763
000289449 0247_ $$2ISSN$$a0267-8357
000289449 0247_ $$2ISSN$$a1464-3804
000289449 0247_ $$2altmetric$$aaltmetric:162402817
000289449 037__ $$aDKFZ-2024-00771
000289449 041__ $$aEnglish
000289449 082__ $$a610
000289449 1001_ $$aGiaccherini, M.$$b0
000289449 245__ $$aA pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma.
000289449 260__ $$aOxford$$bOxford Univ. Press$$c2025
000289449 3367_ $$2DRIVER$$aarticle
000289449 3367_ $$2DataCite$$aOutput Types/Journal article
000289449 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1742287928_8523
000289449 3367_ $$2BibTeX$$aARTICLE
000289449 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000289449 3367_ $$00$$2EndNote$$aJournal Article
000289449 500__ $$a2025 Mar 15;40(1):61-70
000289449 520__ $$aPleiotropic variants (i.e., genetic polymorphisms influencing more than one phenotype) are often associated with cancer risk. A scan of pleiotropic variants was successfully conducted ten years ago in relation to pancreatic ductal adenocarcinoma susceptibility. However, in the last decade, genetic association studies performed on several human traits have greatly increased the number of known pleiotropic variants. Based on the hypothesis that variants already associated with a least one trait have a higher probability of association with other traits, 61,052 variants reported to be associated by at least one genome wide association study (GWAS) with at least one human trait were tested in the present study consisting of two phases (discovery and validation), comprising a total of 16,055 pancreatic ductal adenocarcinoma (PDAC) cases and 212,149 controls. The meta-analysis of the two phases showed two loci (10q21.1-rs4948550 (P=6.52×10-5) and 7q36.3-rs288762 (P=3.03×10-5) potentially associated with PDAC risk. 10q21.1-rs4948550 shows a high degree of pleiotropy and it is also associated with colorectal cancer risk while 7q36.3-rs288762 is situated 28,558 base pairs upstream of the Sonic Hedgehog (SHH) gene, which is involved in the cell differentiation process and PDAC etiopathogenesis. In conclusion, none of the single nucleotide polymorphisms (SNPs) showed a formally statistically significant association after correction for multiple testing. However, given their pleiotropic nature and association with various human traits including colorectal cancer, the two SNPs showing the best associations with PDAC risk merit further investigation through fine mapping and ad hoc functional studies.
000289449 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000289449 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000289449 650_7 $$2Other$$agenetic susceptibility
000289449 650_7 $$2Other$$apancreatic cancer
000289449 650_7 $$2Other$$apleiotropy
000289449 650_7 $$2Other$$asingle nucleotide polymorphism
000289449 7001_ $$aRende, M.$$b1
000289449 7001_ $$aGentiluomo, M.$$b2
000289449 7001_ $$aCorradi, C.$$b3
000289449 7001_ $$aArchibugi, L.$$b4
000289449 7001_ $$aErmini, S.$$b5
000289449 7001_ $$aMaiello, E.$$b6
000289449 7001_ $$aMorelli, L.$$b7
000289449 7001_ $$avan Eijck, C. H. J.$$b8
000289449 7001_ $$aCavestro, G. M.$$b9
000289449 7001_ $$aSchneider, M.$$b10
000289449 7001_ $$aMickevicius, A.$$b11
000289449 7001_ $$aAdamonis, K.$$b12
000289449 7001_ $$aBasso, D.$$b13
000289449 7001_ $$aHlavac, V.$$b14
000289449 7001_ $$aGioffreda, D.$$b15
000289449 7001_ $$aTalar-Wojnarowska, R.$$b16
000289449 7001_ $$0P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aSchöttker, B.$$b17$$udkfz
000289449 7001_ $$aLovecek, M.$$b18
000289449 7001_ $$aVanella, G.$$b19
000289449 7001_ $$aGazouli, M.$$b20
000289449 7001_ $$aUno, M.$$b21
000289449 7001_ $$aMalecka-Wojciesko, E.$$b22
000289449 7001_ $$aVodicka, P.$$b23
000289449 7001_ $$aGoetz, M.$$b24
000289449 7001_ $$aBijlsma, M. F.$$b25
000289449 7001_ $$aPetrone, M. C.$$b26
000289449 7001_ $$aBazzocchi, F.$$b27
000289449 7001_ $$aKiudelis, M.$$b28
000289449 7001_ $$aSzentesi, A.$$b29
000289449 7001_ $$aCarrara, S.$$b30
000289449 7001_ $$aNappo, G.$$b31
000289449 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, H.$$b32$$udkfz
000289449 7001_ $$aMilanetto, A. C.$$b33
000289449 7001_ $$aSoucek, P.$$b34
000289449 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, V.$$b35$$udkfz
000289449 7001_ $$aPeduzzi, G.$$b36
000289449 7001_ $$aRizzato, C.$$b37
000289449 7001_ $$aPasquali, C.$$b38
000289449 7001_ $$0P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9$$aChen, Xuechen$$b39$$udkfz
000289449 7001_ $$aCapurso, G.$$b40
000289449 7001_ $$aHackert, T.$$b41
000289449 7001_ $$aBueno-de-Mesquita, B.$$b42
000289449 7001_ $$aUzunoglu, F. G. G.$$b43
000289449 7001_ $$aHegyi, P.$$b44
000289449 7001_ $$aGreenhalf, W.$$b45
000289449 7001_ $$aTheodoropoulos, G. E. E.$$b46
000289449 7001_ $$aSperti, C.$$b47
000289449 7001_ $$aPerri, F.$$b48
000289449 7001_ $$aOliverius, M.$$b49
000289449 7001_ $$aMambrini, A.$$b50
000289449 7001_ $$aTavano, F.$$b51
000289449 7001_ $$aFarinella, R.$$b52
000289449 7001_ $$aArcidiacono, P. G.$$b53
000289449 7001_ $$aLucchesi, M.$$b54
000289449 7001_ $$aBunduc, S.$$b55
000289449 7001_ $$aKupcinskas, J.$$b56
000289449 7001_ $$aDi Franco, G.$$b57
000289449 7001_ $$aStocker, S.$$b58
000289449 7001_ $$aNeoptolemos, J. P.$$b59
000289449 7001_ $$aBambi, F.$$b60
000289449 7001_ $$aJamroziak, K.$$b61
000289449 7001_ $$aTestoni, S. G. G.$$b62
000289449 7001_ $$aAoki, M. N.$$b63
000289449 7001_ $$aMohelnikova-Duchonova, B.$$b64
000289449 7001_ $$aIzbicki, J. R.$$b65
000289449 7001_ $$aPezzilli, R.$$b66
000289449 7001_ $$aLawlor, R. T.$$b67
000289449 7001_ $$aKauffmann, E. F.$$b68
000289449 7001_ $$aLópez de Maturana, E.$$b69
000289449 7001_ $$aMalats, N.$$b70
000289449 7001_ $$0P:(DE-He78)5323704270b6393dcea70186ffd86bca$$aCanzian, F.$$b71$$udkfz
000289449 7001_ $$aCampa, D.$$b72
000289449 773__ $$0PERI:(DE-600)1497468-X$$a10.1093/mutage/geae012$$gp. geae012$$n1$$p61-70$$tMutagenesis$$v40$$x0267-8357$$y2025
000289449 909CO $$ooai:inrepo02.dkfz.de:289449$$pVDB
000289449 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c67a12496b8aac150c0eef888d808d46$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000289449 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b32$$kDKFZ
000289449 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b35$$kDKFZ
000289449 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c392ec8a090dcfbe801f135a6212caf9$$aDeutsches Krebsforschungszentrum$$b39$$kDKFZ
000289449 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)5323704270b6393dcea70186ffd86bca$$aDeutsches Krebsforschungszentrum$$b71$$kDKFZ
000289449 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000289449 9141_ $$y2024
000289449 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000289449 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMUTAGENESIS : 2022$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000289449 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000289449 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x0
000289449 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPrimäre Krebsprävention$$x1
000289449 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000289449 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lEpidemiologie von Krebs$$x3
000289449 9201_ $$0I:(DE-He78)C055-20160331$$kC055$$lGenomische Epidemiologie$$x4
000289449 980__ $$ajournal
000289449 980__ $$aVDB
000289449 980__ $$aI:(DE-He78)C070-20160331
000289449 980__ $$aI:(DE-He78)C120-20160331
000289449 980__ $$aI:(DE-He78)HD01-20160331
000289449 980__ $$aI:(DE-He78)C020-20160331
000289449 980__ $$aI:(DE-He78)C055-20160331
000289449 980__ $$aUNRESTRICTED